PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.74%
Net income growth above 1.5x MRVL's 3.37%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-12.58%
Negative yoy D&A while MRVL is 4.53%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-11.84%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
5.55%
SBC growth while MRVL is negative at -11.88%. John Neff would see competitor possibly controlling share issuance more tightly.
359.79%
Slight usage while MRVL is negative at -954.91%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
171.43%
AR growth well above MRVL's 136.91%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-195.87%
Negative yoy inventory while MRVL is 171.44%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
1035.24%
A yoy AP increase while MRVL is negative at -299.18%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
594.86%
Some yoy usage while MRVL is negative at -218.55%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
213.68%
Well above MRVL's 31.96%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
146.87%
Some CFO growth while MRVL is negative at -43.29%. John Neff would note a short-term liquidity lead over the competitor.
-73.94%
Negative yoy CapEx while MRVL is 17.67%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
244.54%
Less M&A spending yoy vs. MRVL's 663.54%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-239.68%
Negative yoy purchasing while MRVL stands at 33.66%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
66.89%
We have some liquidation growth while MRVL is negative at -56.89%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-150.00%
Both yoy lines negative, with MRVL at -94.92%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-486.85%
Both yoy lines negative, with MRVL at -106.93%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
63.99%
Debt repayment growth of 63.99% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.